Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 21-27 of 27 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1998Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypesCrawley, A.; Yogalingam, G.; Muller, V.; Hopwood, J.
2006Intra-articular enzyme administration for joint disease in feline mucopolysaccharidosis VI: Enzyme dose and intervalAuclair, D.; Hein, L.; Hopwood, J.; Byers, S.
2005Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfataseHarmatz, P.; Ketteridge, D.; Giugliani, R.; Guffon, N.; Teles, E.; Miranda, C.; Yu, Z.; Swiedler, S.; Hopwood, J.
2001Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the Hurler syndromeBraunlin, E.; Rose, A.; Hopwood, J.; Candel, R.; Krivit, W.
2002Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: Implications for the prediction of disease severityWhitfield, P.; Nelson, P.; Sharp, P.; Bindloss, C.; Dean, C.; Ravenscroft, E.; Fong, B.; Fietz, M.; Hopwood, J.; Meikle, P.
2005Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II studyHarmatz, P.; Kramer, W.; Hopwood, J.; Simon, J.; Butensky, E.; Swiedler, S.
1997Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristicsJones, M.; Alroy, J.; Rutledge, J.; Taylor, J.; Alvord Jnr., E.; Toone, J.; Applegarth, D.; Hopwood, J.; Skutelsky, E.; Ianelli, C.; Thorley Lawson, D.; Mitchell Herpolsheimer, C.; Arias, A.; Sharp, P.; Evans, W.; Sillence, D.; Cavanagh, K.